Meta-analysis: percutaneous versus surgical VA-ECMO decannulation demonstrates no clear differences in most outcomes, with a signal toward lower infection.
Masashi Kawabori, Chris A Jackel, Jo-Ann Nugent, Anna Y Johnson, Tony Mangino, Jamel Ortoleva
{"title":"Meta-analysis: percutaneous versus surgical VA-ECMO decannulation demonstrates no clear differences in most outcomes, with a signal toward lower infection.","authors":"Masashi Kawabori, Chris A Jackel, Jo-Ann Nugent, Anna Y Johnson, Tony Mangino, Jamel Ortoleva","doi":"10.1007/s10047-026-01562-x","DOIUrl":null,"url":null,"abstract":"<p><p>Venoarterial Extracorporeal Membrane Oxygenation (ECMO) is a life-support therapy for critical cardiac or respiratory failure, and decannulation requires arterial access closure. The traditional surgical repair is effective but carries risks inherent to invasive procedures. Percutaneous vascular access closure has been developed as a less invasive alternative, though direct comparative evidence has been limited. We performed a systematic review and meta-analysis of 10 studies published between 2011 and 2024, encompassing 1074 patients and comparing surgical closure versus percutaneous closure. Outcomes assessed included limb infection, ischemia, pseudoaneurysm, bleeding events, ECMO duration, and in-hospital mortality. Results demonstrated no statistically significant differences across most outcomes, including limb ischemia (OR = 0.79; 95% CI 0.44-1.40; p = 0.415), pseudoaneurysm (OR = 0.88; 95% CI 0.45-1.72; p = 0.704), bleeding events (OR = 0.48; 95% CI 0.08-2.82; p = 0.316), ECMO duration (Mean Difference = - 25.4711; 95% CI = - 63.7896-12.8474; p = 0.1639) and mortality (OR = 0.74; 95% CI 0.50-1.10; p = 0.134). In contrast, the pooled OR indicated a significant 94.1% decrease in odds of infection associated with percutaneous closure (OR = 0.06; 95% CI = 0.02-0.17; p = 0.002). No heterogeneity was identified (I<sup>2</sup> = 0%), and meta-regression results were non-significant, suggesting that the device type did not serve as a modifier (p = 0.23).Overall, this analysis reflects the current state of the literature and does not demonstrate consistent differences between percutaneous and surgical approaches across most outcomes. While percutaneous closure may be associated with lower odds of infection, this finding should be interpreted cautiously given the limited number and observational nature of the included studies. However, these results highlight that infection may be an important outcome to prioritize in future investigations. Larger, prospective investigations are needed to better define the comparative effectiveness and safety of these approaches.</p>","PeriodicalId":15177,"journal":{"name":"Journal of Artificial Organs","volume":"29 3","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2026-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Artificial Organs","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s10047-026-01562-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Venoarterial Extracorporeal Membrane Oxygenation (ECMO) is a life-support therapy for critical cardiac or respiratory failure, and decannulation requires arterial access closure. The traditional surgical repair is effective but carries risks inherent to invasive procedures. Percutaneous vascular access closure has been developed as a less invasive alternative, though direct comparative evidence has been limited. We performed a systematic review and meta-analysis of 10 studies published between 2011 and 2024, encompassing 1074 patients and comparing surgical closure versus percutaneous closure. Outcomes assessed included limb infection, ischemia, pseudoaneurysm, bleeding events, ECMO duration, and in-hospital mortality. Results demonstrated no statistically significant differences across most outcomes, including limb ischemia (OR = 0.79; 95% CI 0.44-1.40; p = 0.415), pseudoaneurysm (OR = 0.88; 95% CI 0.45-1.72; p = 0.704), bleeding events (OR = 0.48; 95% CI 0.08-2.82; p = 0.316), ECMO duration (Mean Difference = - 25.4711; 95% CI = - 63.7896-12.8474; p = 0.1639) and mortality (OR = 0.74; 95% CI 0.50-1.10; p = 0.134). In contrast, the pooled OR indicated a significant 94.1% decrease in odds of infection associated with percutaneous closure (OR = 0.06; 95% CI = 0.02-0.17; p = 0.002). No heterogeneity was identified (I2 = 0%), and meta-regression results were non-significant, suggesting that the device type did not serve as a modifier (p = 0.23).Overall, this analysis reflects the current state of the literature and does not demonstrate consistent differences between percutaneous and surgical approaches across most outcomes. While percutaneous closure may be associated with lower odds of infection, this finding should be interpreted cautiously given the limited number and observational nature of the included studies. However, these results highlight that infection may be an important outcome to prioritize in future investigations. Larger, prospective investigations are needed to better define the comparative effectiveness and safety of these approaches.
静脉体外膜氧合(ECMO)是危重心脏或呼吸衰竭的生命支持治疗,而去脉环术需要动脉通路关闭。传统的手术修复是有效的,但有侵入性手术固有的风险。虽然直接的比较证据有限,但经皮血管通路关闭已成为一种侵入性较小的替代方法。我们对2011年至2024年间发表的10项研究进行了系统回顾和荟萃分析,其中包括1074名患者,并比较了手术缝合和经皮缝合。评估的结果包括肢体感染、缺血、假性动脉瘤、出血事件、ECMO持续时间和住院死亡率。结果显示大多数结局无统计学差异,包括肢体缺血(OR = 0.79; 95% CI 0.44-1.40; p = 0.415)、假性动脉瘤(OR = 0.88; 95% CI 0.45-1.72; p = 0.704)、出血事件(OR = 0.48; 95% CI 0.08-2.82; p = 0.316)、ECMO持续时间(平均差异= - 25.4711;95% CI = - 63.7896-12.8474; p = 0.1639)和死亡率(OR = 0.74; 95% CI 0.50-1.10; p = 0.134)。相比之下,合并OR显示经皮缝合术相关感染的几率显著降低94.1% (OR = 0.06; 95% CI = 0.02-0.17; p = 0.002)。未发现异质性(I2 = 0%), meta回归结果无显著性,提示器械类型不作为修饰因子(p = 0.23)。总的来说,该分析反映了文献的现状,并没有证明在大多数结果中经皮和手术入路之间存在一致的差异。虽然经皮缝合术可能与较低的感染几率有关,但考虑到所纳入研究的数量有限和观察性,这一发现应谨慎解释。然而,这些结果强调感染可能是未来研究中优先考虑的重要结果。需要更大规模的前瞻性研究来更好地确定这些方法的相对有效性和安全性。
期刊介绍:
The aim of the Journal of Artificial Organs is to introduce to colleagues worldwide a broad spectrum of important new achievements in the field of artificial organs, ranging from fundamental research to clinical applications. The scope of the Journal of Artificial Organs encompasses but is not restricted to blood purification, cardiovascular intervention, biomaterials, and artificial metabolic organs. Additionally, the journal will cover technical and industrial innovations. Membership in the Japanese Society for Artificial Organs is not a prerequisite for submission.